BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System

  Twist Bioscience Corporation and Element Biosciences, Inc. today announced a collaboration to develop the Twist for Element, Exome 2.0 plus Comprehensive Exome Spike-in Workflow for Element’s AVITI™ System.

  February 6, 2024

   · 

  6 min read
• Business

  Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency

  Medidata and Sanofi Vaccines, today announced a collaboration to harness Medidata eCOA to deploy in vaccine studies.

  February 6, 2024

   · 

  4 min read
• Deals

  Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2024

  Inozyme Pharma, Inc. today announced that it granted stock options to four new employees to purchase shares of the Company’s common stock.

  February 6, 2024

   · 

  1 min read
• Pharm Country

  SELLAS Announces Publication of Preclinical Data on its Highly Selective CDK9 Inhibitor, SLS009, in Oncotarget

  SELLAS Life Sciences Group, Inc. today announced a publication in Oncotarget revealing the underlying mechanisms of action behind the anti-proliferative effects of SLS009 (formerly GFH009).

  February 6, 2024

   · 

  4 min read
• Business

  Nanalysis Achieves Record Revenue in Q4

  Nanalysis Scientific Corp., a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate of Q4 2023 unaudited revenue and highlights some other recent business accomplishments.

  February 6, 2024

   · 

  5 min read
• Business

  Vistagen to Report Fiscal Year 2024 Third Quarter Financial Results and Host Corporate Update Conference Call on February 13, 2024

  Vistagen today announced it will host a conference call and webcast on Tuesday, February 13, 2024, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to report results for its fiscal year 2024 third quarter ended December 31, 2023 and provide a corporate update.

  February 6, 2024

   · 

  2 min read
• Biotech Bay

  RenovoRx CEO Issues Letter to Shareholders

  Recent financing will drive Company towards second interim analysis on pivotal Phase III TIGeR-PaC clinical trial by end of 2024.

  February 6, 2024

   · 

  10 min read
• Deals

  Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock

  Jasper Therapeutics, Inc. announced today the pricing of its underwritten offering of 3,900,000 shares of its common stock.

  February 6, 2024

   · 

  5 min read
• BioMidwest

  Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

  Sensus Healthcare, Inc. announces a new multi-faceted collaboration with CureRays, a radiation oncology specialist organization based in Atlanta and Grass Valley, Calif.

  February 6, 2024

   · 

  3 min read
• Deals

  BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market

  BioRestorative Therapies, Inc. today announced it has entered into agreements with certain holders of its existing warrants exercisable for 3,351,580 shares of its common stock.

  February 6, 2024

   · 

  4 min read